IMMUNIC director awarded 25,370 stock options
IMMUNIC, INC. director Simona Skerjanec received a grant of stock options covering 25,370 shares of common stock.
Sentiment and the balance of points
Rhea-AI Sentiment reads the wording of the document, how positive or negative its language is on a 1 to 5 scale. The balance of points shown with the takes weighs what the document actually discloses, so the two can disagree, for example when a trial that missed its main goal is described in upbeat language.
Form Type
4
Rhea-AI Filing Summary
IMMUNIC, INC. director Simona Skerjanec received a grant of stock options covering 25,370 shares of common stock. The options have an exercise price of $14.80 per share and expire on July 5, 2036. They vest in monthly increments over one year from the grant date, and following this grant she holds 25,370 options directly.
Insider Trade Summary
Grant/Award: 25,370 shares
Grant/Award
1 txn
Insider
Skerjanec Simona
Role
Director
| Type | Security | Shares | Price | Value |
|---|---|---|---|---|
| Grant/Award | Stock Option | 25,370 | $0.00 | $0.00 |
Holdings After Transaction:
Stock Option — 25,370 contracts (Direct)
Footnotes (1)
- F1. The option vests in monthly increments over a period of one year from the grant date.
Key Figures
Options granted: 25,370 options
Exercise price: $14.80 per share
Underlying shares: 25,370 shares
+3 more
6 metrics
Options granted
25,370 options
Stock option award to director on July 5, 2026
Exercise price
$14.80 per share
Strike price for IMMUNIC common stock underlying options
Underlying shares
25,370 shares
IMMUNIC common stock underlying the stock options
Expiration date
July 5, 2036
Final expiration of granted stock options
Post-transaction options held
25,370 options
Derivative securities beneficially owned following transaction
Vesting schedule
Monthly over one year
Options vest in monthly increments from grant date
Key Terms
Stock Option, exercise price, Common Stock, expiration date, +1 more
5 terms
Stock Option financial
"security_title: "Stock Option""
A stock option is a contract that gives you the right to buy or sell a company's stock at a specific price within a certain time frame. People use them to potentially make money if the stock's price moves favorably or to protect against losses. It's like holding a coupon that can be used to buy or sell stock at a set price later on.
exercise price financial
"conversion_or_exercise_price: "14.8000""
The exercise price is the fixed amount at which you can buy or sell an asset, like a stock, when using an options contract. It matters because it helps determine whether exercising the option will be profitable or not, depending on the current market price. Think of it as the set price you agree on today to buy or sell later.
Common Stock financial
"underlying_security_title: "Common Stock""
Common stock represents ownership shares in a company, giving investors a stake in its success and a say in important decisions through voting rights. It is the most common type of stock traded on markets and can provide income through dividends, as well as potential for value growth. For investors, holding common stock means sharing in the company’s profits and risks.
expiration date financial
"expiration_date: "2036-07-05T00:00:00.000Z""
The expiration date is the deadline after which a financial contract, such as an option or a futures agreement, is no longer valid or can be exercised. It matters to investors because it determines the timeframe during which they can take action or benefit from the contract, similar to how a coupon or a food item has a limited period of usefulness. Once the expiration date passes, the contract loses its value or ability to be used.
vests in monthly increments financial
"The option vests in monthly increments over a period of one year"
FAQ
AI-generated questions and answers. How Rhea-AI works. Not financial advice.
What insider transaction did IMMUNIC (IMUX) report for Simona Skerjanec?
IMMUNIC reported that director Simona Skerjanec received a grant of stock options for 25,370 shares of common stock. The options were awarded at an exercise price of $14.80 per share and represent a compensation-related acquisition, not an open-market purchase or sale.
What are the key terms of Simona Skerjanec’s IMMUNIC (IMUX) stock options?
The granted stock options cover 25,370 shares of IMMUNIC common stock at an exercise price of $14.80 per share. They expire on July 5, 2036 and vest in monthly increments over one year from the grant date, aligning with typical director compensation practices.
How many IMMUNIC (IMUX) options does Simona Skerjanec hold after this Form 4?
After this grant, Simona Skerjanec holds 25,370 IMMUNIC stock options directly. This entire position comes from the reported award, as the Form 4 shows 25,370 derivative securities beneficially owned following the transaction, with no additional derivative holdings listed.
Is the IMMUNIC (IMUX) Form 4 transaction an insider buy or a compensation grant?
The Form 4 reflects a compensation grant, not an open-market insider buy. The transaction is coded as an award (Code A), described as a grant, award, or other acquisition, with no cash price paid and a fixed $14.80 exercise price for future potential share acquisition.
When do Simona Skerjanec’s IMMUNIC (IMUX) options vest and expire?
The options vest in monthly increments over one year from the grant date, spreading vesting across twelve months. They carry a long-term expiration date of July 5, 2036, giving a multi-year window during which vested options can potentially be exercised at $14.80 per share.
AI-generated analysis. How Rhea-AI works. Not financial advice.
Accepted by SEC EDGAR
Learn about SEC filing dates